Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.
Noah S. Kalman, MD, MBA
Advertisement
Noah S. Kalman, MD, MBA, is a radiation oncologist specializing in the treatment of gynecologic, head and neck, thoracic and pediatric cancers, melanoma and non-melanoma skin cancers, and sarcoma at Miami Cancer Institute of Baptist Health Medical Group.
Articles by Noah S. Kalman, MD, MBA
Noah S. Kalman, MD, MBA, discusses how oncologists can determine the best course of action for the treatment and management of a patient with thyroid cancer.
Noah S. Kalman, MD, MBA, discusses the most common types of thyroid cancer and their respective prognoses.
Advertisement
Latest Updated Articles
Kalman Unveils Insights on Thyroid Cancer Prognosis and TreatmentsPublished: October 24th 2024 | Updated: October 24th 2024
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
